Skin microbes in infancy may give an early signal of future eczema or food allergy

Eczema and food allergy often begin in infancy. Identifying which infants are likely to develop these conditions earlier than current clinical signs could change monitoring and management. The study reported that the tiny organisms living on a baby's skin—collectively called the skin microbiome—showed measurable differences months before eczema or food allergy were diagnosed.

Researchers led by Washington State University's College of Veterinary Medicine compared the skin microbiome of infants who later developed eczema or food allergy with those who did not. They observed distinct microbial changes in the at-risk infants well in advance of clinical diagnosis. The results were published in the journal Allergy.

Why the skin microbiome could be useful

Practical implications for caregivers and clinicians

These findings are not a diagnostic test ready for routine clinical use. However, they point to a possible future in which a simple skin swab could be part of early-risk assessment. For now, the practical steps remain conventional: watch for early skin symptoms, seek medical evaluation when eczema or allergic reactions are suspected, and follow established guidance on allergy testing and management.

Key next steps include validating the specific microbial patterns in broader infant populations, determining how early and how reliably the patterns predict disease, and testing whether interventions that alter the skin microbiome change the risk. Researchers will also aim to clarify mechanisms linking microbes and immune responses that lead to eczema or food allergy.

Changes in infants' skin microbes appear to precede clinical eczema and food allergy, according to a study led by Washington State University and published in Allergy. The finding suggests a potential role for skin-microbiome sampling as an early-risk tool, but more research is needed before it can be used in routine care.